421 related articles for article (PubMed ID: 23119085)
1. Culture conditions affect cardiac differentiation potential of human pluripotent stem cells.
Ojala M; Rajala K; Pekkanen-Mattila M; Miettinen M; Huhtala H; Aalto-Setälä K
PLoS One; 2012; 7(10):e48659. PubMed ID: 23119085
[TBL] [Abstract][Full Text] [Related]
2. Development of a Xeno-Free Feeder-Layer System from Human Umbilical Cord Mesenchymal Stem Cells for Prolonged Expansion of Human Induced Pluripotent Stem Cells in Culture.
Zou Q; Wu M; Zhong L; Fan Z; Zhang B; Chen Q; Ma F
PLoS One; 2016; 11(2):e0149023. PubMed ID: 26882313
[TBL] [Abstract][Full Text] [Related]
3. Noggin maintains pluripotency of human embryonic stem cells grown on Matrigel.
Chaturvedi G; Simone PD; Ain R; Soares MJ; Wolfe MW
Cell Prolif; 2009 Aug; 42(4):425-33. PubMed ID: 19500111
[TBL] [Abstract][Full Text] [Related]
4. Robust protocol for feeder-free adaptation of cryopreserved human pluripotent stem cells.
Aalders J; Van den Vreken N; Popovic M; Mishra S; Heindryckx B; van Hengel J
In Vitro Cell Dev Biol Anim; 2019 Dec; 55(10):777-783. PubMed ID: 31664691
[TBL] [Abstract][Full Text] [Related]
5. Dosage and cell line dependent inhibitory effect of bFGF supplement in human pluripotent stem cell culture on inactivated human mesenchymal stem cells.
Quang T; Marquez M; Blanco G; Zhao Y
PLoS One; 2014; 9(1):e86031. PubMed ID: 24465853
[TBL] [Abstract][Full Text] [Related]
6. Human iPS cell-derived fibroblast-like cells as feeder layers for iPS cell derivation and expansion.
Du SH; Tay JC; Chen C; Tay FC; Tan WK; Li ZD; Wang S
J Biosci Bioeng; 2015 Aug; 120(2):210-7. PubMed ID: 25622768
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
Meng G; Liu S; Rancourt DE
Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of mouse embryonic stem cells into endoderm without embryoid body formation.
Kim PT; Hoffman BG; Plesner A; Helgason CD; Verchere CB; Chung SW; Warnock GL; Mui AL; Ong CJ
PLoS One; 2010 Nov; 5(11):e14146. PubMed ID: 21152387
[TBL] [Abstract][Full Text] [Related]
9. Reduction of N-glycolylneuraminic acid in human induced pluripotent stem cells generated or cultured under feeder- and serum-free defined conditions.
Hayashi Y; Chan T; Warashina M; Fukuda M; Ariizumi T; Okabayashi K; Takayama N; Otsu M; Eto K; Furue MK; Michiue T; Ohnuma K; Nakauchi H; Asashima M
PLoS One; 2010 Nov; 5(11):e14099. PubMed ID: 21124894
[TBL] [Abstract][Full Text] [Related]
10. Preparation of mouse embryonic fibroblast cells suitable for culturing human embryonic and induced pluripotent stem cells.
Jozefczuk J; Drews K; Adjaye J
J Vis Exp; 2012 Jun; (64):. PubMed ID: 22760161
[TBL] [Abstract][Full Text] [Related]
11. Autologous feeder cells from embryoid body outgrowth support the long-term growth of human embryonic stem cells more effectively than those from direct differentiation.
Fu X; Toh WS; Liu H; Lu K; Li M; Hande MP; Cao T
Tissue Eng Part C Methods; 2010 Aug; 16(4):719-33. PubMed ID: 19911961
[TBL] [Abstract][Full Text] [Related]
12. Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings.
Villa-Diaz LG; Ross AM; Lahann J; Krebsbach PH
Stem Cells; 2013 Jan; 31(1):1-7. PubMed ID: 23081828
[TBL] [Abstract][Full Text] [Related]
13. Establishment of a feeder and serum-free culture system for human embryonic stem cells.
Wang L; Zhang R; Ma R; Jia G; Jian S; Zeng X; Xiong Z; Li B; Li C; Lv Z; Bai X
Zygote; 2020 Jun; 28(3):175-182. PubMed ID: 31965957
[TBL] [Abstract][Full Text] [Related]
14. A novel in vitro method for detecting undifferentiated human pluripotent stem cells as impurities in cell therapy products using a highly efficient culture system.
Tano K; Yasuda S; Kuroda T; Saito H; Umezawa A; Sato Y
PLoS One; 2014; 9(10):e110496. PubMed ID: 25347300
[TBL] [Abstract][Full Text] [Related]
15. Culture, Adaptation, and Expansion of Pluripotent Stem Cells.
Brehm JL; Ludwig TE
Methods Mol Biol; 2017; 1590():139-150. PubMed ID: 28353267
[TBL] [Abstract][Full Text] [Related]
16. 3D microcarrier system for efficient differentiation of human pluripotent stem cells into hematopoietic cells without feeders and serum [corrected].
Lu SJ; Kelley T; Feng Q; Chen A; Reuveny S; Lanza R; Oh SK
Regen Med; 2013 Jul; 8(4):413-24. PubMed ID: 23826696
[TBL] [Abstract][Full Text] [Related]
17. An autogeneic feeder cell system that efficiently supports growth of undifferentiated human embryonic stem cells.
Stojkovic P; Lako M; Stewart R; Przyborski S; Armstrong L; Evans J; Murdoch A; Strachan T; Stojkovic M
Stem Cells; 2005 Mar; 23(3):306-14. PubMed ID: 15749925
[TBL] [Abstract][Full Text] [Related]
18. Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers.
Beattie GM; Lopez AD; Bucay N; Hinton A; Firpo MT; King CC; Hayek A
Stem Cells; 2005 Apr; 23(4):489-95. PubMed ID: 15790770
[TBL] [Abstract][Full Text] [Related]
19. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
Abraham S; Sheridan SD; Miller B; Rao RR
Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
[TBL] [Abstract][Full Text] [Related]
20. Characterization and therapeutic potential of induced pluripotent stem cell-derived cardiovascular progenitor cells.
Nsair A; Schenke-Layland K; Van Handel B; Evseenko D; Kahn M; Zhao P; Mendelis J; Heydarkhan S; Awaji O; Vottler M; Geist S; Chyu J; Gago-Lopez N; Crooks GM; Plath K; Goldhaber J; Mikkola HK; MacLellan WR
PLoS One; 2012; 7(10):e45603. PubMed ID: 23056209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
